The association between clinical outcome and CD8 + lymphocytic infiltration in advanced stages of colorectal cancer differs by latent virus infection in tumour tissue Aims: In the near future, an immunoscore based on the quantification of lymphocytic populations can be expected as a fundamental supplement of colorectal cancer (CRC) classification. This study explored whether latent viral infection has an influence on prognostically relevant host immunity in CRC.
The association between clinical outcome and CD8 + lymphocytic infiltration in advanced stages of colorectal cancer differs by latent virus infection in tumour tissue Aims: In the near future, an immunoscore based on the quantification of lymphocytic populations can be expected as a fundamental supplement of colorectal cancer (CRC) classification. This study explored whether latent viral infection has an influence on prognostically relevant host immunity in CRC.
Methods and results: CD8
+ lymphocytic infiltration in three tumour compartments of 121 CRC was compared with clinical data and occurrence of latent infection with herpes simplex virus (HSV1, HSV2), cytomegalovirus (CMV), human papillomavirus (HPV16 and HPV18) in the tumour tissue, which was determined by polymerase chain reaction (PCR). Intraepithelial CD8 + lymphocytic infiltration (IE CD8+ ) showed a trend towards correlation with clinical stage (P = 0.073), significant differences between CRC with and without metastases (P = 0.001) and a significant correlation with overall survival (OS, P = 0.001). Each of these three clinical parameters showed a significant link to IE CD8+ in the virus DNAnegative (P-values: 0.001-0.036), but no significant differences in the virus DNA-positive subgroup, which is consistent with a moderating effect of virus DNA on these associations. A significant correlation of CD8 + infiltration in the invasive margin (IM CD8+ ) with OS (P = 0.016) was also moderated by virus DNA. Conclusion: Our data suggest a possible influence of latent viral infection on the association between clinical outcome and CD8
Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer-related death worldwide. 1 Accurate classification of tumours is required for the assessment of prognosis and guidance of therapy. The current staging of CRC depends currently upon histopathological criteria such as depth of tumour invasion (T), spread to local lymph nodes (N) and distant metastases (M) and, additionally, on tumour cell differentiation as defined by the World Health Organization (WHO). [2] [3] [4] [5] Data obtained from large CRC cohort studies point to number, type and location of tumour immune infiltrates as indicators for disease-free and overall survival beyond that predicted by the American Joint Committee (AJCC)/Union Internationale Contre le Cancer (UICC) tumour-nodemetastasis (TNM) staging. [6] [7] [8] [9] Consequently, an immunoscore based on the numeration of two lymphocyte populations, both in the core and in the invasive margin of tumours, will shortly be introduced as a component of cancer classification. 9 The independence of this immunoreaction from other well-established prognostic tumour-related biomarkers such as microsatellite instability (MSI), BRAF mutation and LINE-1 hypomethylation, has already been proved. [9] [10] [11] Additionally, recent studies have explored the immunomodulatory function of pathophysiological, dietary and environmental factors such as the patient's body mass index, chronic alcohol consumption, marine x-3 polyunsaturated fatty acid intake, nutrition regimens and infection with Fusobacterium nucleatum. [12] [13] [14] [15] [16] Taking into account that, in different studies, up to 32% and 97% of CRC showed DNA and/or protein of a-, b-, c-herpesvirus and (HPV), 17 respectively, interaction of latent virus infection with antitumour immunoreaction might be theoretically possible. An impact of a-and c-herpesvirus latency on CD8 + T cells has already been demonstrated in mice models. 18, 19 Furthermore, detailed study on human gastric cancer revealed that Epstein-Barr virus (EBV + ) tumour cells cause a massive recruitment of CD8 + lymphocytes. 20 However, in human colorectal cancer (CRC), a link between latent virus infection and prognostic important immunoreaction has not been investigated so far. Therefore, this study was performed to explore the prognostic information of CD8 + lymphocytic infiltration in the epithelium (IE CD8+ ), in the interepithelial stroma (ST CD8+ ) and in the invasive margin (IM CD8+ ) of CRC and to elucidate whether potential correlations between CD8 + immunoreaction and prognostic markers are influenced by virus DNA in the tumours.
Materials and methods

T I S S U E S A M P L I N G A N D S E L E C T I O N
A total of 121 formalin-fixed paraffin-embedded (FFPE) CRC samples from resection specimens of 120 patients were collected from the tissue archive (1999) (2000) (2001) (2002) (2003) (2004) (2005) at the Department of Pathology, Southern Norwegian Hospital Trust, Kristiansand. The material was partly included in a previous study. lymphocytic infiltration in the stroma parallel to the invasive front of the tumour, and at least parts of these infiltrates must show contact with the outermost epithelial border of the tumour. Any CD8 + lymphocytic infiltration in the stroma between the tumour epithelium, which did not meet the criteria for IM CD8+ , was categorized as ST CD8+ . Ulcerated luminal borders or areas with necrosis were not considered for quantification. Criteria for evaluation of IE CD8+ , ST CD8+ and IM CD8+ were determined in a consensus conference prior to the review process and are displayed in the headings of Tables 1-3 . For assessment of ST CD8+ and IM CD8+ , we used modified Graham-Appelman 22 criteria with an arbitrary cut-off level of ≥50 cells to acknowledge lymphocytic aggregates of major importance. Further details are described in the Supporting information.
D N A I S O L A T I O N , V I R U S D N A A M P L I F I C A T I O N A N D E L E C T R O P H O R E S I S
DNA isolation from paraffin-embedded tumour tissue and separately prepared, histologically confirmed tumour-free resection margins was performed as described previously. 21 Viral DNA sequences were amplified in a multiplex PCR reaction with fluorescence-labelled primers. For cytomegalovirus (CMV) and EBV, DNA primer CE1 was used as forward primer. For HPV16 and HPV18, we used MY-11 as forward primer. Primer sequences and references are displayed in the Supporting information, Table S1 . Multiplex PCR was performed in a volume of 12.5 ll in the GeneAmp â PCR system 9700 (Applied Biosystems, Weiterstadt, Germany) with 2-5 ng of DNA as template in 15 mM Tris/HCl and 50 mM KCl, with 200 lM dNTPs, 1.5 mM MgCl 2 , 0.1-0.5 lM primers and 1.5 units AmpliTaq Gold Polymerase (Applied Biosystems). DNA extracts from the uterine cervix, the gastrointestinal tract and lymph nodes with known HPV16, HPV18, HSV1, HSV2, CMV and EBV infection, respectively, were used as positive controls. PCR conditions were initial denaturation and activation step of 8 min at 95°C, 30 cycles of 1 min at 94°C, 1 min at 60°C and 2 min at 72°C and a 60-min final elongation step at 60°C. Evaluation of PCR products was performed on ABI310 or ABI3130 Genetic Analysers (Weiterstadt, Germany) using GeneMapper â ID Software version 3.2 with selfdesigned panels and bins sets. A semi-quantitative comparison of the amount of virus DNA in tumour and normal tissue was performed by measuring peak height and peak area after capillary electrophoresis. If either peak height or peak area varied between tumour and normal tissue by more than 5%, a difference in virus DNA load was stated.
S T A T I S T I C A L A N A L Y S I S
Data were analysed using mainly Fisher's exact and v 2 tests. For investigation of the survival data (time to event), Kaplan-Meier survival rates were calculated and plotted, and the log-rank test was used for testing the difference in time between groups. Furthermore, the effect of multiple categorical predictors on the outcome (time to event) was analysed with hierarchical Cox regression models. Virus DNA (both in general and stratified into herpesviridae and HPV) was analysed as a moderator of the effect on the association between CD8 + lymphocytic infiltration and clinical parameters (stage, metastatic status and survival) by splitting the data by the virus variable, and the effect was compared between subgroups (cross-tabulation with significance tests or KaplanMeier analysis with significance tests). In all analyses, a P-value of less than 0.05 (two-tailed) was considered statistically significant. All data were analysed by D. Keller Statistics Service (K€ urnach, Germany) using SPSS 
Results
Clinical data of the patients, histopathological characteristics of the tumours, the quantity of CD8 + lymphocytes in three different tumour compartments and detection of virus DNA in the tumours are listed in Tables 1-3 . Distant metastases, which occurred within 6 months after primary diagnosis of CRC, were considered as synchronous and metastases with occurrence beyond 6 months after primary diagnosis were registered as metachronous (i.e. recurrence), according to the definition by Mekenkamp et al. 23 At the time of surgery, none of the patients showed symptoms of acute virus infection according to the electronic patient charts. Postoperative chemotherapy was given to 78 (65%) patients; none received preoperative chemotherapy. Examples for each score of IE CD8+ , ST CD8+ and IM CD8+ are displayed in Figure 1 .
Exact numeration of IE CD8+ showed very good interobserver agreement for a dichotomous scoring system (high versus non-high) and good agreement for scoring into four categories (negative, low, moderate, high) (j = 0.80 and 0.70, respectively). At first evaluation, semiquantitative assessment with a dichotomous model and a four-categories system showed moderate and fair agreement for ST CD8+ (j = 0.50 and 0.38, respectively) and poor agreement (both models) for IM CD8+ (j = 0.16 and 0.12, respectively). In all discordant cases, agreement was achieved either between first and third reviews or second and third reviews.
Virus DNA was detected in 28 (23.1%) of CRC tissues; in more detail, DNA of HSV1/2, EBV, CMV and HPV16/18 was found in 18 (14.9%), three (2.5%), three (2.5%) and six (5%) of CRC tissues, respectively. Two CRC showed DNA of two viruses (HSV1 with EBV and EBV with CMV, respectively, Figure 2 ). Semi-quantitative assessment of viral DNA load in CRC and corresponding normal tissues revealed that DNA of CMV, EBV and HPV16/18 was found in CRC tissue either exclusively or in higher amounts than in normal tissue (all 100%). In contrast, HSV1/2 DNA was detected mainly in equal amounts in CRC and normal tissue or in lower amounts in CRC tissue (77.8%; Supporting information, Table S2 ).
Considering only segments of the colon (without rectum), high IE CD8+ was not found in the distal, but in the proximal colon (P = 0.0296, Table 1 ). However, adjustment for tumour location by Cox regression analysis did not change the significant correlation between IE CD8+ and OS (Supporting information, Table S3 ). Marginally and clearly significant differences between IE CD8+ and clinical stage, metastatic status and OS, respectively, and the correlation between IM CD8+ and OS were moderated by viral DNA (Figures 3 and 4) . Mainly, these moderating effects did not differ by virus type, but the + lymphocytic infiltration: D in the epithelium, E in the stroma, F in the invasive margin. In both figures, E and F, the asterisk marks a focus with <50 CD8 + cells in 1 mm 2 area, consistent with score 1. G-I, Cases with moderate CD8 + lymphocytic infiltration: G in the epithelium, H in the stroma (the asterisks mark several foci with <50 CD8 + cells in 1 mm 2 area, consistent with score 2), I in the invasive margin (the asterisk marks a focus with >50 CD8 + cells in 1 mm 2 area, consistent with score 2). J-L, Cases with high CD8 + lymphocytic infiltration: J in the epithelium, K in the stroma (the asterisk marks a follicle containing >50 CD8 + cells in 1 mm 2 area, consistent with score 3), L in the invasive margin (the asterisks mark two follicles containing >50 CD8 + cells in 1 mm 2 area, consistent with score 3).
correlation between IE CD8+ and OS was possibly moderated more strongly by herpesvirus than HPV DNA, as indicated by larger differences between the Pvalues (Supporting information, Figures S1 and S2 ). Viral DNA was not detected in CRC with high IE CD8+, which was identified as a subgroup with high prognostic importance in the dichotomous model (Figures 3 and 4) . A moderating effect of viral DNA on the significant correlation between IE CD8+ and DFS in stage 3 patients (Supporting information, Figure S3 ) could not be explored due to the small size of this group.
Discussion
This study investigated whether viral DNA has an influence on prognostically relevant host immunity in CRC. The intratumoural DNA detection rate for each virus type in this study was close to the lower end of the range reported in the literature. 17 Detection of CMV, EBV and HPV16/18 in CRC tissue, either exclusively or in higher amounts than in normal tissue, could point to a role of these viral DNA types in colorectal carcinogenesis, but due to its semiquantitative approach and the low number of virus DNA-positive CRC, this study was not sufficient to prove a putative role of viral pathogens as a cause of CRC. 17 Taking into account the different cell tropism of these viruses, CD8 + lymphocytic infiltration in three different tumour compartments was either numerated exactly (tumour epithelium IE CD8+ ) or assessed semiquantitatively (tumour stroma ST CD8+ and invasive margin IM CD8+ ), as introduced by Naito et al. and developed further (pattern-based) by Ogino et al.
11,24
Patients with advanced clinical tumour stages were chosen for this retrospective evaluation, because prevention of metachronous metastases in stage 3 patients and improvement of survival in patients with synchronous metastases (stage 4) are the major clinical issues in CRC. This study design caused a preponderance of pT3 and pT4 CRC in the investigated cohort, which could explain the low number of cases with high IE CD8+ . High IE CD8+ was seen only in patients with absence of synchronous and metachronous metastases (i.e. stage 3 patients without recurrence), which is in line with a recent publication describing tumour dissemination to distant sites as critically influenced by immunoreaction in the tumour microenvironment. 25 Furthermore, overall survival (OS) correlated with IE CD8+ and IM CD8+ and better disease-free survival (DFS) in stage 3 patients was associated with high IE CD8 . These results are in accordance with the previously reported prognostic importance of tumour lymphocytic reaction. [6] [7] [8] 10, 11 In contrast to a study by Naito et al., 24 we could not find a link between ST CD8+ and clinical outcome. With some reservations due to the small sample size, we could demonstrate that the association between .e. patients with metachronous and synchronous metastases. Differences between stages (A, marginally significant) and metastatic status (B, significant) found in the entire cohort were significant in the viral DNA-negative subgroups (C,D), but not in the viral DNA-positive subgroups (E,F), which is consistent with a moderating effect of viral DNA. G,H, Significant differences between stages and metastatic status in a dichotomized model. Corrected significance levels (HolmBonferroni method) for analyses (two per family) investigating the same hypothesis: A (P = 0.073) and G (P = 0.026), B (P = 0.001) and H (P = 0.0018), C (P = 0.072) and E (P = 0.793), D (P = 0.002) and F (P = 0.163). Adjusted P-values are still consistent with a moderating effect of viral DNA on the correlation between IE_CD8 and metastatic status.
the favourable outcome-associated high IE CD8+ score, whereas the moderating viral DNA effect on the correlation between IM CD8+ and OS is difficult to explain. We were not able to demonstrate a direct link between virus DNA and CD8 + lymphocytic infiltration in the three investigated tumour compartments, but the idea of an immunomodulatory effect of microbial DNA is supported by a recent study which showed an inverse correlation between the amount of Fusobacterium nucleatum DNA and T cell density in CRC tissue. 16 To the best of our knowledge, similar studies focusing on the influence of viral DNA on T cell counts in CRC material do not exist. However, experimental evidence indicating an immunosuppressive effect of viral DNA can form a base for our hypothesis. Persistent viral infection can cause immunosenescence or T cell exhaustion in different ways, with HSV inducing functional T cell memory and CMV causing partial loss of function. 26, 27 Furthermore, viral persistence may facilitate dysfunction of CD8 + T cells and their response to cancer indirectly; for example, by causing functional exhaustion of antigen-presenting dendritic cells, adaptive epigenetic diversification of natural killer cells with altered signalling (CMV) and triggering miRNA-dependent release of immuno-inhibitory cytokines (EBV). Even if our data fitted these experimental concepts, we have to acknowledge limitations of this study. The application of a previously published cut-off level for high CD8 + lymphocytic infiltration 7 caused unequal distribution of cases in the four levels of the CD8 + scoring system with, in some categories, a small random sample size. Furthermore, indistinct borders of lymphocytic foci and difficult delineation of the analysed tumour regions, which were also experienced by other investigators, 24 resulted in inappropriate agreement between the first and second reviewers of ST CD8+ and IM CD8+ . This issue could be resolved sufficiently by a third review, but underlines the necessity of standardized procedures with automated cell-counting, as recommended by the founders of the Immunoscore. 9 Advanced techniques would also allow the use of more objective assessment criteria for lymphoid reaction in the stroma and invasive margin of CRC, such as size-based and density-based criteria. 34, 35 In our study, standardised . Kaplan-Meier curves of overall survival (OS) stratified by intra-epithelial (IE) and invasive margin (IM) CD8 + scores: A,B, for all patients; C,D for viral DNA-negative subgroups, E,F for viral DNA-positive subgroups, G,H for all patients in a dichotomized model. Significant differences in OS between IE_CD8 scores in the virus DNA negative (C), but not in the virus DNA-positive subgroup (E) were consistent with a moderating effect of viral DNA on this correlation. Analogically, significant differences in OS between IM_CD8 scores in the virus DNA-positive (F), but not in the virus DNA-negative subgroup (D), were consistent with a moderating effect of viral DNA on this correlation. Corrected significance levels (Holm-Bonferroni method) for analyses (two per family) investigating the same hypothesis: A (P = 0.002) and G (P = 0.002), B (P = 0.032) and H (P = 0.061), C (P = 0.004) and E (P = 0.247), D (P = 0.094) and F (P = 0.034). Adjusted P-values are still consistent with a moderating effect of viral DNA on the correlations between OS and CD8 + scores (IE and IM). measurement of these parameters was not possible due to the use of four different microscope brands, and counting of lymphocytes per aggregate with an arbitrary cut-off level was a compromise which might have biased our results. Furthermore, this study included only a limited spectrum of microbial pathogens, applied only one non-quantifying technique for detection of viral DNA and did not determine which tumour compartment or cell type (neoplastic, stromal or haematopoietic) contained viral DNA. Additionally, we cannot exclude the possibility of reverse causation, which was also mentioned as potential bias in a study on bacterial DNA and T cell density in CRC. 16 Although it is possible that immune cells may eradicate viral DNA, experimental evidence indicates a suppressive effect of persistent viral infection on T cell function. 28 Nevertheless, our data hint at a possible influence of latent viral infection on the association between clinical outcome and CD8 + lymphocytic infiltration in CRC tissue. Provided that these findings can be confirmed by large cohort studies, whether potential interaction between microbial pathogens and host immunity in CRC might bias prognostic immunoscores, or harbour the possibility for new therapeutic strategies, should be explored further. 
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